Maisons-Alfort, France

Patrick Van Dreden

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Maisons-Alfort, FR (2000 - 2001)
  • Brennilis, FR (2014)

Company Filing History:


Years Active: 2000-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Patrick Van Dreden

Introduction

Patrick Van Dreden is a notable inventor based in Maisons-Alfort, France. He has made significant contributions to the field of hemostasis, particularly in blood coagulation disorders. With a total of 3 patents, his work has advanced the understanding and detection of coagulation diseases.

Latest Patents

One of his latest patents is a method for in vitro assay of the circulating tissue factor, which is crucial for detecting coagulation diseases. This invention addresses blood coagulation disorders linked to abnormal expression of tissue factor. The method allows for the assaying of circulating tissue factor activity in biological samples, particularly blood samples collected from patients. Another significant patent is a process for determining resistance to activated protein C in human plasma. This process involves mixing a test specimen of plasma with specific reactants and determining coagulation times under various conditions.

Career Highlights

Throughout his career, Patrick has worked with prominent companies such as Diagnostica Stago and Société Diagnostica-Stago. His experience in these organizations has contributed to his expertise in the field of coagulation and hemostasis.

Collaborations

Patrick has collaborated with notable colleagues, including Aurelie Rousseau and Barry Woodhams. These partnerships have further enriched his research and innovations in the medical field.

Conclusion

Patrick Van Dreden's contributions to the field of hemostasis through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the detection and understanding of coagulation diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…